Azacitidine (AZA) and Donor Lymphocyte Infusion (DLI) Is a Viable Salvage Approach for Chimerism-Only Relapse Following Haploidentical Donor Allogeneic Blood or Marrow Transplantation (BMT)

Transplantation and Cellular Therapy 2026

View at publisher

Authors: Isabela Stemple, Alexander Joseph Ambinder, Kathryn Yarkony, Richard John Jones, Tania Jain

DOI: 10.1016/j.jtct.2025.12.576

Cited by: 0

Fields of Study & Subjects

Hematopoietic Stem Cell Transplantation Acute Myeloid Leukemia Research Renal Transplantation Outcomes and Treatments